Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)

Clinical trial NCT01145846 · UNKNOWN

Trial details

NCT number: NCT01145846
Sponsor: Cooperative Study Group A for Hematology
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2010-05-01
Primary completion: 2012-04-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.